Table 1 summarizes key epigenetic markers implicated in early lung cancer detection. These include DNA methylation markers, such as RASSF1A and CDKN2A, non-coding RNA regulators, like miR-21 and MALAT1 [73], and emerging diagnostic tools based on histone modifications and liquid biopsy technologies. The gene discussed is CDKN2A; the disease is lung cancer.